Baker Bros. Advisors LP Celcuity Inc. Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Celcuity Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 4,257,735 shares of CELC stock, worth $55.8 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
4,257,735
Previous 2,678,553
58.96%
Holding current value
$55.8 Million
Previous $35.1 Million
22.77%
% of portfolio
0.51%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding CELC
# of Institutions
98Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Bvf Inc San Francisco, CA3.47MShares$45.4 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$33.7 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$30.9 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$21.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.46MShares$19.1 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $196M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...